Enantioselective analysis of citalopram and demethylcitalopram in human and rat plasma by chiral LC-MS/MS: Application to pharmacokinetics

Chirality

Volumn 19, Issue 10, 2007, Pages 793-801

  Rocha, Adriana ^a   Marques, Maria P ^a   Coelho, Eduardo B ^a   Lanchote, Vera L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Citalopram; Enantiomers; LC MS MS; Metabolism; Pharmacokinetics

Indexed keywords

CITALOPRAM; DEMETHYLCITALOPRAM; DRUG DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BLOOD; BLOOD ANALYSIS; CHEMISTRY; HUMAN; LIQUID CHROMATOGRAPHY; MALE; RAT; STEREOISOMERISM; TANDEM MASS SPECTROMETRY; WISTAR RAT;

ANIMALS; BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, LIQUID; CITALOPRAM; HUMANS; MALE; RATS; RATS, WISTAR; SEROTONIN UPTAKE INHIBITORS; STEREOISOMERISM; TANDEM MASS SPECTROMETRY;

EID: 38449102717     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.20452     Document Type: Article

References (22)

1. Olesen OV, Linnet K. Studies on the stereoselective metabolism of citalopram by human liver microsomes and cDNA-expressed cytochrome P450 enzymes. Pharmacology 1999;59: 298-309.
2. Zheng Z, Jamour M, Klotz U. Stereoselective HPLC-assay for citalopram and its metabolites. Ther Drug Monit 2000;22: 219-224.
3. Moltke LLV, Greenblatt DJ, Giancarlo GM, Granda BW, Harmatz JS, Sharder RI. Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram. Drug Metabol Dispos 2001;29: 1102-1109.
4. Baumann P, Zullino DF, EAP CB. Enantiomers' potential in psychopharmacology - A critical analysis with special emphasis on the antidepressant escitalopram. Eur Neuropsychopharmacol 2002;12: 433-444.
5. Spigset O, Hägg S, Stegmayr B, Dahqvist R. Citalopram pharmacokinetics in patients with chronic renal failure and the effect of hemodialysis. Eur J Clin Pharmacol 2000;56: 699-703.
6. Shidu J, Priskorn M, Poulsen M, Segonzac A, Grollier G, Larsen F. Steady-state pharmacokinetics of enantiomers of citalopram and its metabolites in humans. Chirality 1997;9: 686-692.
7. Wikell C, Apelqvist G, Carlsson B, Hjorth S, Bergqvist PBF, Kugelberg FC, Ahlner J, Bengtsson F. Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats. Clin Neuropharmacol 1999; 22: 327-336.
8. Kugelberg FC, Apelqvist G, Carlsson B, Ahlner J, Bengtsson F. In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats. Br J Pharmacol 2001;132: 1683-1690.
9. Kugelberg FC, Carlsson B, Ahlner J, Bengtsson F. Stereoselective single- dose kinetics of citalopram and its metabolites in rats. Chirality 2003;15: 622-629.
10. Rochat B, Amey M, Baumann P. Analysis of enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients using chiral reverse-phase liquid chromatography. Ther Drug Monit 1995;17: 273-279.
11. Rochat B, Amey M, Van Gelderen H, Testa B, Baumann P. Determination of the enantiomers of citalopram, its demethylated and propionic acid metabolites in human plasma by chiral HPLC. Chirality 1995;7: 389-395.
12. Haupt D. Determination of citalopram enantiomers in human plasma by liquid chromatographic separation on a chiral-AGP column. J Chromatogr B 1996;685: 299-305.
13. Kosel M, Eap CB, Amey M, Baumann P. Analysis of enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography. J Chromatogr B 1998;719: 234-238.
14. Andersen S, Halvorsen TG, Pedersen-Bjergaard S, Rasmussen KE, Tanum L, Refsun H. Stereospecific determination of citalopram and desmethylcitalopram by capillary electrophoresis and liquid-phase microextraction. J Pharm Biomed Anal 2003;33: 263-273.
15. Mandrioli R, Fanali S, Pucci V, Raggi MA. Enantiomeric separation of citalopram and its metabolites by capillary electrophoresis. Electrophoresis 2003;24: 2608-2616.
16. Dalgaard L, Larsen C. Metabolism and excretion of citalopram in man: identification of O-acyl- and N-glucuronides. Xenobiotica 1999; 29: 1033-1041.
17. Idborg-Björkman H, Edlund PO, Kvalheim OM, Schuppe-Koistinen I, Jacobsson SP. Screening of biomarker in rat urine using LC/electrospray ionization-MS and two-way data analysis. Anal Chem 2003;75: 4784-4792.
18. Idborg H, Edlund PO, Jacobsson SP. Multivariate approaches for efficient detection of potential metabolites from liquid chromatography/mass spectrometry data. Rapid CommunMass Spectrom 2004;18: 944-954.
19. Pistos C, Panderi I, Atta-Politou J. Liquid chromatography-positive ion electrospray mass spectometry method for the quantification of citalopram in human plasma. J Chromatogr B 2004;810: 235-244.
20. Singh SS, Shah H, Gupta S, Jain M, Sharma K, Thakkar P, Shah R. Liquid chromatography-electrospray ionization mass spectrometry method for the determination of escitalopram in human plasma and its application in bioequivalence study. J Chromatogr B 2004;811: 209-215.
21. Carlsson B, Olsson G, Reis M, Walinder J, Nordin C, Lundmark J, Scordo MG, Dahl ML, Bengtsson F, Ahlner J. Enantioselective analysis of citalopram and metabolites in adolescents. Ther Drug Monit 2001;23: 658-664.
22. Herrlin K, Yasui-Furukori N, Tybring G, Widén J, Gustafsson LL, Bertilsson L. Metabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes. Br J Clin Pharmacol 2003;56: 415-421.